These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
250 related articles for article (PubMed ID: 15225174)
1. Pathophysiological characteristics of patients with non-erosive reflux disease differ from those of patients with functional heartburn. Frazzoni M; De Micheli E; Zentilin P; Savarino V Aliment Pharmacol Ther; 2004 Jul; 20(1):81-8. PubMed ID: 15225174 [TBL] [Abstract][Full Text] [Related]
2. Pathophysiological characteristics of the various forms of gastro-oesophageal reflux disease. Spectrum disease or distinct phenotypic presentations? Frazzoni M; Manno M; De Micheli E; Savarino V Dig Liver Dis; 2006 Sep; 38(9):643-8. PubMed ID: 16627016 [TBL] [Abstract][Full Text] [Related]
3. The extent of oesophageal acid exposure overlap among the different gastro-oesophageal reflux disease groups. Shapiro M; Green C; Faybush EM; Esquivel RF; Fass R Aliment Pharmacol Ther; 2006 Jan; 23(2):321-9. PubMed ID: 16393313 [TBL] [Abstract][Full Text] [Related]
4. The added value of quantitative analysis of on-therapy impedance-pH parameters in distinguishing refractory non-erosive reflux disease from functional heartburn. Frazzoni M; Conigliaro R; Mirante VG; Melotti G Neurogastroenterol Motil; 2012 Feb; 24(2):141-6, e87. PubMed ID: 21988704 [TBL] [Abstract][Full Text] [Related]
5. Acid-related oesophageal sensitivity, not dysmotility, differentiates subgroups of patients with non-erosive reflux disease. Thoua NM; Khoo D; Kalantzis C; Emmanuel AV Aliment Pharmacol Ther; 2008 Mar; 27(5):396-403. PubMed ID: 18081729 [TBL] [Abstract][Full Text] [Related]
6. The added value of impedance-pH monitoring to Rome III criteria in distinguishing functional heartburn from non-erosive reflux disease. Savarino E; Marabotto E; Zentilin P; Frazzoni M; Sammito G; Bonfanti D; Sconfienza L; Assandri L; Gemignani L; Malesci A; Savarino V Dig Liver Dis; 2011 Jul; 43(7):542-7. PubMed ID: 21376679 [TBL] [Abstract][Full Text] [Related]
7. Overweight is a risk factor for both erosive and non-erosive reflux disease. Savarino E; Zentilin P; Marabotto E; Bonfanti D; Inferrera S; Assandri L; Sammito G; Gemignani L; Furnari M; Dulbecco P; Savarino V Dig Liver Dis; 2011 Dec; 43(12):940-5. PubMed ID: 21944835 [TBL] [Abstract][Full Text] [Related]
8. Effect of hiatal hernia on proximal oesophageal acid clearance in gastro-oesophageal reflux disease patients. Emerenziani S; Habib FI; Ribolsi M; Caviglia R; Guarino MP; Petitti T; Cicala M Aliment Pharmacol Ther; 2006 Mar; 23(6):751-7. PubMed ID: 16556177 [TBL] [Abstract][Full Text] [Related]
9. Famotidine vs. omeprazole: a prospective randomized multicentre trial to determine efficacy in non-erosive gastro-oesophageal reflux disease. Fujiwara Y; Higuchi K; Nebiki H; Chono S; Uno H; Kitada K; Satoh H; Nakagawa K; Kobayashi K; Tominaga K; Watanabe T; Oshitani N; Arakawa T Aliment Pharmacol Ther; 2005 Jun; 21 Suppl 2():10-8. PubMed ID: 15943841 [TBL] [Abstract][Full Text] [Related]
10. Efficacy of famotidine and omeprazole in healing symptoms of non-erosive gastro-oesophageal reflux disease: randomized-controlled study of gastro-oesophageal reflux disease. Wada T; Sasaki M; Kataoka H; Tanida S; Itoh K; Ogasawara N; Oshima T; Togawa S; Kubota E; Yamada T; Mori Y; Fujita F; Ohara H; Nakao H; Sobue S; Joh T; Itoh M Aliment Pharmacol Ther; 2005 Jun; 21 Suppl 2():2-9. PubMed ID: 15943840 [TBL] [Abstract][Full Text] [Related]
11. Distinct clinical characteristics between patients with nonerosive reflux disease and those with reflux esophagitis. Wu JC; Cheung CM; Wong VW; Sung JJ Clin Gastroenterol Hepatol; 2007 Jun; 5(6):690-5. PubMed ID: 17481961 [TBL] [Abstract][Full Text] [Related]
12. Antireflux surgery for non-erosive and erosive reflux disease in community practice. Thibault R; Coron E; Sébille V; Sacher-Huvelin S; Bruley des Varannes S; Gournay J; Galmiche JP Aliment Pharmacol Ther; 2006 Aug; 24(4):621-32. PubMed ID: 16907894 [TBL] [Abstract][Full Text] [Related]
14. Stratification and symptom characteristics of non-erosive reflux disease based on acid and duodenogastroesophageal reflux. Xiong LS; Chen MH; Lin JK; Hu PJ J Gastroenterol Hepatol; 2008 Feb; 23(2):290-5. PubMed ID: 17924953 [TBL] [Abstract][Full Text] [Related]
15. Functional heartburn patients demonstrate traits of functional bowel disorder but lack a uniform increase of chemoreceptor sensitivity to acid. Shapiro M; Green C; Bautista JM; Peru RL; Malagon IB; Corvo M; Risner-Adler S; Beeler JN; Tuchinsky I; Fass R Am J Gastroenterol; 2006 May; 101(5):1084-91. PubMed ID: 16573776 [TBL] [Abstract][Full Text] [Related]
16. Oesophageal motility and bolus transit abnormalities increase in parallel with the severity of gastro-oesophageal reflux disease. Savarino E; Gemignani L; Pohl D; Zentilin P; Dulbecco P; Assandri L; Marabotto E; Bonfanti D; Inferrera S; Fazio V; Malesci A; Tutuian R; Savarino V Aliment Pharmacol Ther; 2011 Aug; 34(4):476-86. PubMed ID: 21671968 [TBL] [Abstract][Full Text] [Related]
17. Heartburn during sleep: a clinical marker of gastro-oesophageal reflux disease in morbidly obese patients. Fornari F; Madalosso CA; Callegari-Jacques SM; Gurski RR Neurogastroenterol Motil; 2009 Feb; 21(2):136-42. PubMed ID: 18651868 [TBL] [Abstract][Full Text] [Related]
18. Presence of gas in the refluxate enhances reflux perception in non-erosive patients with physiological acid exposure of the oesophagus. Emerenziani S; Sifrim D; Habib FI; Ribolsi M; Guarino MP; Rizzi M; Caviglia R; Petitti T; Cicala M Gut; 2008 Apr; 57(4):443-7. PubMed ID: 17766596 [TBL] [Abstract][Full Text] [Related]
19. Oesophageal and cardia function in patients with paraoesophageal hiatus hernia. Zaninotto G; Costantini M; Anselmino M; Boccù C; Molena D; Rigotti P; Merigliano S; Ancona E Br J Surg; 1997 Aug; 84(8):1163-7. PubMed ID: 9278669 [TBL] [Abstract][Full Text] [Related]
20. Differences in clinical characteristics between patients with endoscopy-negative reflux disease and erosive esophagitis in Japan. Fujiwara Y; Higuchi K; Shiba M; Yamamori K; Watanabe Y; Sasaki E; Tominaga K; Watanabe T; Oshitani N; Arakawa T Am J Gastroenterol; 2005 Apr; 100(4):754-8. PubMed ID: 15784015 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]